BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Drug Development

  Intercept Pharma Is One Step Closer to Filing for Approval of First NASH Treatment

  Intercept Pharma plans to seek regulatory approval in the U.S. and Europe in the second half of this year.

  February 19, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Teva Eyes 25 Percent of the $750 Million EpiPen Market by Year’s End

  Teva Pharmaceuticals is expecting big things from its generic EpiPen. The company snagged approval for its generic version of Mylan’s EpiPen Auto-Injector in August 2018.

  February 19, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Japanese Researchers Will Use Stem Cells to Treat Spinal Cord Injuries in Groundbreaking Clinical Trial

  Four patients with spinal cord injuries will receive nerve cells made from induce pluripotent stem cells in hopes of regaining sensation and mobility lost as a result of the injury.

  February 19, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  Two Pharma Companies File Chapter 11 Bankruptcy

  The season surrounding Valentine’s Day brings out the love in many people, but for two pharma companies, this year was a year of heartbreak. California-based Aradigm Corporation and New Jersey-based Immune Pharmaceuticals both filed Chapter 11.

  February 19, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Menopause and Estrogen Decline Could Show a Link to Alzheimer’s Disease

  As pharma companies struggle with developing a treatment for Alzheimer’s disease, researchers continue to find evidence that links the dreaded form of dementia to other medical and health issues. The latest news suggests a potential link between Alzheimer’s and menopause.

  February 19, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  FDA

  Novo Nordisk Snags FDA Approval for Hemophilia A Treatment

  On Tuesday, Novo Nordisk said the FDA approved its Biologics License Application for Esperoct (turoctocog alfa pegol) formerly known as N8-GP, for the treatment of children and adults with hemophilia A.

  February 19, 2019

   · 

  2 min read

   · 

  Alex Keown
• Business

  Nutricion Center NC and ADL Bionatur Solutions sign a strategic alliance to tackle weight control by rebalancing the gut microbiome

  ADL Bionatur Solutions, by partnering with Nutricion Center NC, opens up big opportunities in the Spanish pharmacy sector: reaching over 2,000 direct sales points; and 20,000 pharmacies

  February 19, 2019

   · 

  4 min read
• FDA

  Medtronic Receives FDA Breakthrough Designation for Developing Personalized Closed Loop Insulin Pump System for Diabetes Management

  Medtronic plc, the global leader in medical technology, announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration for its Personalized Closed Loop insulin pump system, currently in development.

  February 19, 2019

   · 

  2 min read
• Business

  Medtronic Reports 2019 Third Quarter Financial Results

  Medtronic plc announced financial results for its third quarter of fiscal year 2019, which ended January 25, 2019.

  February 19, 2019

   · 

  13 min read
• Deals

  ASIT biotech: 2019 Financial Calendar

  ASIT biotech, a Belgian biopharmaceutical company specialized in the research and development of innovative allergy immunotherapy products, announces its preliminary financial calendar for 2019.

  February 19, 2019

   · 

  1 min read